Comparative analysis of clinical outcomes and healthcare resource utilization (HRU) in patients (pts) with newly diagnosed (nd) acute myeloid leukemia (aml) unfit for high-intensity chemotherapy treated with venetoclax (VEN) vs other therapies: Results from the AML real world evidence (ARC) initiative Meeting Abstract
| Authors: | Desai, P.; Garcia, J. S.; Zeidner, J. F.; Abedin, S.; Wolach, O.; Vachhani, P.; Moshe, Y.; Pollyea, D. A.; Lai, C.; LeBlanc, T. W.; Xavier, M.; Nachmias, B.; Chen, E. C.; Bathini, S.; Bhatti, I.; Bui, C. N.; Guérin, A.; Burne, R.; Ma, E.; Grunspan, M.; Frankel, N.; Goldberg, A. D. |
| Abstract Title: | Comparative analysis of clinical outcomes and healthcare resource utilization (HRU) in patients (pts) with newly diagnosed (nd) acute myeloid leukemia (aml) unfit for high-intensity chemotherapy treated with venetoclax (VEN) vs other therapies: Results from the AML real world evidence (ARC) initiative |
| Meeting Title: | 65th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 142 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2023 Dec 9-12 |
| Meeting Location: | San Deigo, CA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2023-11-02 |
| Start Page: | 5173 |
| Language: | English |
| ACCESSION: | WOS:001159900801101 |
| DOI: | 10.1182/blood-2023-173283 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract -- Source: Wos |
